Skip to main content
Top
Published in: Journal of Medical Ultrasonics 4/2020

01-10-2020 | Fatty Liver | Special Feature: Review Article

Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Authors: Masayoshi Kage, Shinichi Aishima, Hironori Kusano, Hirohisa Yano

Published in: Journal of Medical Ultrasonics | Issue 4/2020

Login to get access

Abstract

Nonalcoholic fatty liver disease (NAFLD) is based on the concept of pathological morphology as well as clinical findings, and is broadly categorized into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). The differential diagnosis between NAFL and NASH is important because NASH has the potential to progress to cirrhosis and hepatocellular carcinoma. NAFL is simple hepatic steatosis without hepatocellular injury, while NASH is characterized by macrovesicular steatosis, inflammation, and ballooning hepatocytes with a predominantly centrilobular (zone 3) distribution. Liver biopsy is a useful test for diagnosing NAFLD, but it is invasive. Therefore, various noninvasive methods including diagnostic imaging have been developed in recent years. To verify their usefulness, it is necessary to clarify in detail how the pathological findings are reflected in the image findings as imaging and histopathological findings are closely related. We describe the main histological features of NAFLD, i.e., steatosis, inflammation, ballooning hepatocytes, Mallory-Denk bodies, and fibrosis, as well as the evolutional process to liver cirrhosis.
Literature
1.
go back to reference Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. CrossRef Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. CrossRef
2.
go back to reference Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of disease: practice Guideline by the American Association for the Study of Liver Diseases. Am College Gastroenterol Assoc Hepatol. 2018;67:328–57. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of disease: practice Guideline by the American Association for the Study of Liver Diseases. Am College Gastroenterol Assoc Hepatol. 2018;67:328–57.
3.
go back to reference Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo ClinProc. 1980;55:434–8. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo ClinProc. 1980;55:434–8.
4.
go back to reference Matteoni CA, Younssi ZM, Gramlich T, et al. Non nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9. CrossRef Matteoni CA, Younssi ZM, Gramlich T, et al. Non nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9. CrossRef
5.
go back to reference Hashimoto E, Tokushige K, Ludwig J. Diagnosis and classification of non-alcoholic steatohepatitis: current concepts and remaining challenges. Hepatol Res. 2015;45:20–8. CrossRef Hashimoto E, Tokushige K, Ludwig J. Diagnosis and classification of non-alcoholic steatohepatitis: current concepts and remaining challenges. Hepatol Res. 2015;45:20–8. CrossRef
6.
go back to reference Kuwashiro T, Takahashi H, Hyogo H, et al. Discordant pathological diagnosis of non-alcoholic fatty liver disease: a prospective multicenter study. JGH. 2020;4:497–502. CrossRef Kuwashiro T, Takahashi H, Hyogo H, et al. Discordant pathological diagnosis of non-alcoholic fatty liver disease: a prospective multicenter study. JGH. 2020;4:497–502. CrossRef
7.
go back to reference Gambino RG, Cassader M, Pagono G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease accuracy severity. Ann Med. 2011;43:617–49. CrossRef Gambino RG, Cassader M, Pagono G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease accuracy severity. Ann Med. 2011;43:617–49. CrossRef
8.
go back to reference Cassinoto C, Boursier J, Ledinghen V, et al. (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan and ARFI with liver biopsy. Hepatology. 2016;63:1817–27. CrossRef Cassinoto C, Boursier J, Ledinghen V, et al. (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan and ARFI with liver biopsy. Hepatology. 2016;63:1817–27. CrossRef
9.
go back to reference Oeda S, Takahashi H, Imajo K, et al. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study. J Gastoenterol. 2020;55:428–40. CrossRef Oeda S, Takahashi H, Imajo K, et al. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study. J Gastoenterol. 2020;55:428–40. CrossRef
10.
go back to reference Tada T, Iijima H, Kobayashi N, et al. Usefulness of attenuation imaging with an ultrasound saner for the evaluation of hepatic steatosis. Ultrasound Med Biol. 2019;45:2679–87. CrossRef Tada T, Iijima H, Kobayashi N, et al. Usefulness of attenuation imaging with an ultrasound saner for the evaluation of hepatic steatosis. Ultrasound Med Biol. 2019;45:2679–87. CrossRef
11.
go back to reference Vuppalanchi R, Siddiqui MS, Van Natta ML, et al. Performance characteristics of vibration-controled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018;67:134–44. CrossRef Vuppalanchi R, Siddiqui MS, Van Natta ML, et al. Performance characteristics of vibration-controled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018;67:134–44. CrossRef
12.
go back to reference Noureddin M, Lam J, Peterson MR, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013;58:1930–40. CrossRef Noureddin M, Lam J, Peterson MR, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013;58:1930–40. CrossRef
13.
go back to reference Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626–37. CrossRef Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626–37. CrossRef
14.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74. CrossRef Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74. CrossRef
15.
go back to reference Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21. CrossRef Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21. CrossRef
16.
go back to reference Brunt EM, Kleiner DE, Laura W, et al. Portal chronic inflammation in nonalcoholic fatty liver (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:809–20. CrossRef Brunt EM, Kleiner DE, Laura W, et al. Portal chronic inflammation in nonalcoholic fatty liver (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:809–20. CrossRef
17.
go back to reference Sakamoto M, Tsujikawa H, Effendi K, et al. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Pathol Int. 2017;67:1–7. CrossRef Sakamoto M, Tsujikawa H, Effendi K, et al. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Pathol Int. 2017;67:1–7. CrossRef
18.
go back to reference Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis; inter-protocol agreement and ability to predict liver-related mortality. Hepatopoly. 2011;53:1874–82. CrossRef Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis; inter-protocol agreement and ability to predict liver-related mortality. Hepatopoly. 2011;53:1874–82. CrossRef
19.
go back to reference Sanyal AJ, Brunt EM, Kleiner DE, et al. End points and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344–53. CrossRef Sanyal AJ, Brunt EM, Kleiner DE, et al. End points and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344–53. CrossRef
20.
go back to reference Zatloukal K, Denk H, Stumptner C, et al. From Mallory to Mallory-Denk inclusion bodies: what, how and why? Exp Cell Res. 2007;313:2033–49. CrossRef Zatloukal K, Denk H, Stumptner C, et al. From Mallory to Mallory-Denk inclusion bodies: what, how and why? Exp Cell Res. 2007;313:2033–49. CrossRef
21.
go back to reference Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroentelology. 1948;95:1056–62. CrossRef Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroentelology. 1948;95:1056–62. CrossRef
22.
go back to reference Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver diseases. Gastroenterology. 2015;149:389–97. CrossRef Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver diseases. Gastroenterology. 2015;149:389–97. CrossRef
23.
go back to reference Latry P, Bioulac-Sage P, Echinard E, et al. Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients. Hum Pathol. 1987;18:775–80. CrossRef Latry P, Bioulac-Sage P, Echinard E, et al. Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients. Hum Pathol. 1987;18:775–80. CrossRef
24.
go back to reference Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 1987;82:650–4. PubMed Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 1987;82:650–4. PubMed
Metadata
Title
Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Authors
Masayoshi Kage
Shinichi Aishima
Hironori Kusano
Hirohisa Yano
Publication date
01-10-2020
Publisher
Springer Singapore
Keyword
Fatty Liver
Published in
Journal of Medical Ultrasonics / Issue 4/2020
Print ISSN: 1346-4523
Electronic ISSN: 1613-2254
DOI
https://doi.org/10.1007/s10396-020-01061-3

Other articles of this Issue 4/2020

Journal of Medical Ultrasonics 4/2020 Go to the issue